Hepatitis B reactivation in a renal transplant patient due to a surface antigen mutant strain: A case report

Transplantation Proceedings

Volumn 44, Issue 9, 2012, Pages 2773-2775

  Fylaktou, A ^a   Daoudaki, M ^b   Dimou, V ^a   Sianou, E ^a   Papaventsis, D ^a   Mavrovouniotis, I ^a   Fouzas, I ^b   Papanikolaou, V ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; VIRUS ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SUBSTITUTION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CONFERENCE PAPER; FOCAL GLOMERULOSCLEROSIS; GENOTYPE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS LOAD; VIRUS MUTANT; VIRUS REACTIVATION; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BASE SEQUENCE; BIOLOGICAL MARKERS; CYCLOSPORINE; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYCOPHENOLIC ACID; PREDNISOLONE; TREATMENT OUTCOME; VIRAL LOAD; VIRUS ACTIVATION;

EID: 84869001372     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.09.011     Document Type: Conference Paper

References (14)

1. W. Yeo, J.P. Johnson Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy Hepatology 43 2006 209
2. C.M. Mastroianni, M. Lichtner, R. Citton Current trends in management of hepatitis B virus reactivation in the biologic therapy era World J Gastroenterol 17 2011 3881
3. R. Liang How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation Blood 113 2009 3147
4. J.H. Hoofnagle Reactivation of hepatitis B Hepatology 49 2009 S156
5. U. Protzer-Knolle, U. Naumann, R. Bartenschlanger Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 27 1998 254
6. F. Rodriguez-Frias, M. Buti, R. Jardi Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis b, chronic hepatitis B, and hepatitis B liver cirrhosis before and after liver transplantation Liver 19 1999 177
7. E. Kajiwara, Y. Tanaka, T. Ohashi Hepatitis B caused by a hepatitis B surface antigen escape mutant J Gastroenterol 43 2008 243
8. R. Liang How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation Blood 113 2009 3147
9. D. Vassilopoulos Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes Eur J Intern Med 22 2011 572
10. A.D. Salama, C.D. Pusey Drug insight: rituximab in renal disease and transplantation Nat Clin Pract Nephrol 2 2006 221
11. M.W. van den Hoogen, L.B. Hilbrands Use of monoclonal antibodies in renal transplantation Immunotherapy 3 2011 871
12. A. Fylaktou, D. Papaventsis, M. Daoudaki Molecular epidemiology of chronic hepatitis B virus infection in Greece J Med Virol 83 2011 245
13. T.H. Westhoff, F. Jochimsen, A. Schmittel Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy Blood 102 2003 1930
14. J. Gossmann, E.H. Scheuermann, H.G. Kachel Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution Clin Transplant 23 2009 431